MADD Antibody Blocking Peptide

• Reactivity: Hu
• Applications: AC
• Concentration: 0.2 mg/ml

MADD Antibody Blocking Peptide Summary

• Description: A blocking peptide containing 19 amino acids near the carboxy terminus of human MADD.

  Source: Synthetic

  (Accession #: AAD12154)

• Source: Synthetic
• Protein/Peptide Type: Antibody Blocking Peptide
• Gene: MADD
• Purity: N/A

Applications/Dilutions

• Dilutions:
  • Antibody Competition
• Application Notes: This peptide is useful as a blocking peptide for NBP1-77033.
  
  For further blocking peptide related protocol, click here.

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• Preservative: 0.02% Sodium Azide
• Concentration: 0.2 mg/ml
• Purity: N/A

Alternate Names for MADD Antibody Blocking Peptide

• DENNFLJ36300
• Differentially expressed in normal and neoplastic cells
• FLJ35600
• IG20
• Insulinoma glucagonoma clone 20
• insulinoma-glucagonoma protein 20
• KIAA0358RAB3GEP
• MAP kinase-activating death domain protein
• MAP-kinase activating death domain
• Rab3 GDP/GTP exchange factor

Background

MAP kinase-activating death domain protein (MADD) is a death domain containing protein that interacts with the death domain of TNF-alpha receptor 1 to activate mitogen-activate protein kinase (MAPK) and transduce apoptotic signals. MADD is a multi-pass membrane protein that exists as multiple alternatively spliced forms.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: MADD